Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanobiological engineering strategies for organoid culture. | APL Bioeng | 2025 | 40688244 | PubTator, text mining | PubMed |
| Extracellular Matrix Signaling Cues: Biological Functions, Diseases, and Therapeutic Targets. | MedComm (2020) | 2025 | 40686923 | PubTator, text mining | PubMed |
| Integrative RNA-sequencing analysis of COPD-related genes in association with individual PM2.5 exposure. | Environ Res | 2025 | 40684981 | PubTator, text mining | PubMed |
| Enhanced neuromorphogenesis of neural stem cells via the optimization of physical stimulus-responsive signaling pathways. | Stem Cell Res Ther | 2025 | 40682198 | PubTator, text mining | PubMed |
| Mechanosensitive ion channels and inflammation: key links in cellular signal transduction. | Inflamm Res | 2025 | 40664752 | PubTator, text mining | PubMed |
| Nitric Oxide Scavenging Alleviates Scar Pruritus by Inhibiting S-Nitrosylation of Transient Receptor Potential Channels and Limiting Calcium Influx. | FASEB J | 2025 | 40637249 | PubTator, text mining | PubMed |
| The role of bile salts in itch receptor activation. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40628364 | PubTator, text mining | PubMed |
| Poly-(D,L)-Lactide-ε-Caprolactone-Methacrylate Is a Suitable Scaffold Material for In Vitro Cartilage Regeneration. | Int J Mol Sci | 2025 | 40565317 | PubTator, text mining | PubMed |
| TRPV2 channels facilitate pulmonary endothelial barrier recovery after ROS-induced permeability. | Redox Biol | 2025 | 40532320 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Physiology and Pathophysiology: Special Issue. | Int J Mol Sci | 2025 | 40430100 | PubTator, text mining | PubMed |
| The Identification of Opioid Receptors and Peptide Precursors in Human DRG Neurons Expressing Pain-Signaling Molecules Confirms Their Potential as Analgesic Targets. | Cells | 2025 | 40422197 | PubTator, text mining | PubMed |
| Selective inhibition of TRPV3 channel by natural rosmarinic acid and its analogs for alleviation of skin lesions through downregulation of NF-κB pathway. | J Biol Chem | 2025 | 40409547 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of TRPV4-KCa2.3 coupling enhancers as novel therapeutic agents for hypertension. | Eur J Med Chem | 2025 | 40409057 | PubTator, text mining | PubMed |
| Piezo1 Is an Early Mediator During Topography-Stimulated Osteogenic Differentiation of Bone Mesenchymal Stem Cells. | J Biomed Mater Res A | 2025 | 40405805 | PubTator, text mining | PubMed |
| Open-source magnetic system for wireless neuromodulations in vitro and for untethered brain stimulation in vivo. | Sci Rep | 2025 | 40404843 | PubTator, text mining | PubMed |
| Bisphenol A Induces Neuronal Apoptosis and Oxidative Stress Through TRPV4 Channel Signaling Pathways: Protective Role of Alpha-Lipoic Acid. | Environ Toxicol | 2025 | 40396745 | PubTator, text mining | PubMed |
| Activation of the mechanosensitive ion channels TRPV4 and PIEZO1 downregulates key regulatory systems in the chondrocyte mechanome. | Connect Tissue Res | 2025 | 40395084 | PubTator, text mining | PubMed |
| Bryostatins 1 and 3 inhibit TRPM8 and modify TRPM8- and TRPV1-mediated lung epithelial cell responses to a proinflammatory stimulus via protein kinase C. | Mol Pharmacol | 2025 | 40378651 | PubTator, text mining | PubMed |
| Implications of mechanosensitive ion channels in the pathogenesis of osteoarthritis: a comprehensive review. | Front Cell Dev Biol | 2025 | 40376614 | PubTator, text mining | PubMed |
| A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channel. | Acta Pharm Sin B | 2025 | 40370548 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=14